Israel - hebreiska - Ministry of Health

padagis israel pharmaceuticals ltd, israel - glipizide - טבליה - glipizide 5 mg - glipizide - glipizide - is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with diabetes mellitus type ii

Israel - hebreiska - Ministry of Health

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

Israel - hebreiska - Ministry of Health

neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

Israel - hebreiska - Ministry of Health

neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

Israel - hebreiska - Ministry of Health

neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.

Israel - hebreiska - Ministry of Health

dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 5 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.

Israel - hebreiska - Ministry of Health

dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 10 mg - enalapril - enalapril - treatment of essntial hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.

Israel - hebreiska - Ministry of Health

dexcel ltd, israel - enalapril maleate - טבליה - enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventricular dysfunction.

Israel - hebreiska - Ministry of Health

cts chemical industries ltd, israel - enalapril maleate - טבליה - enalapril maleate 5 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure.to retard the development of symptomatic heart failure in asymptomatic patients with left ventrcular dysfunction.

Israel - hebreiska - Ministry of Health

cts chemical industries ltd, israel - enalapril maleate - טבליה - enalapril maleate 10 mg - enalapril - enalapril - treatment of essential hypertension, renovascular hypertension congestive heart failure and to reduce mortality in patients with all degrees of heart failure. to retard the development of symptomatic heart failure in asymptomatic patients with left ventrcular dysfunction.